Good morning, team. Here’s your fresh-cut briefing on what shook markets and tech yesterday—and what to track before the opening bell.
Morning Snapshot
Market Commentary
Everyone's fixated on NVIDIA's slump and the OpenAI sprawl, but the most overlooked storm is in biotech. Analysts keep cheering CRISPR Therapeutics AG (CRSP) riding AI-driven drug discovery, yet the FDA pipeline gauntlet and patent skirmishes could derail gains faster than you realize. Betting on gene editing isn't a damn guaranteed win—this could get messy.
Consider the harsh lesson from Amazon Staffers Learning Hard Lesson as Company Cuts Robotics Jobs (Futurism) alongside OpenAI's robotics head quits after company's Pentagon deal: ‘This was about principle' (Business Insider). The push for automation and military AI cash collided this week, revealing that moonshots and GOP-driven defense budgets don't always jive—damn.
It's time to shift focus into the underappreciated corners—keep an eye on That Japanese brand's solid-state EV battery acquisition (Electrek) and Strategic Acquisition in the Field of Uncrewed and Autonomous Systems: Rheinmetall to Gain Majority Stake in DOK-ING (Soldiersystems.net). These plays sit at the intersection of manufacturing innovation and defense expansion, and they might turn out to be the damn contrarian wins your benchmark needs. Don't sit on your hands—get in front of the next leg of the industrial revolution.
📈 Breaking Financial News
Amazon Staffers Learning Hard Lesson as Company Cuts Robotics Jobs
Who's automating the automators? The post Amazon Staffers Learning Hard Lesson as Company Cuts Robotics Jobs appeared first on Futurism.
OpenAI's robotics head quits after company's Pentagon deal: ‘This was about principle'
Caitlin Kalinowski says she is quitting OpenAI over concerns that the technology could be used for mass surveillance and autonomous weapons.
RR Investor Alert: Richtech Robotics (RR) Facing Securities Class Action Amid Questions About Possible Pump and Dump – Hagens Berman
Investors who lost money in RR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
This Japanese brand bought out an all-solid-state EV battery company, and it’s not Toyota
Another major Japanese automaker is jumping into the race for the “holy grail” of EV batteries after buying out an all-solid-state battery business.
The fallout over OpenAI's Pentagon deal is growing
Since OpenAI agreed to share its technology with the Pentagon last week, the company has faced a torrent of bad news.
🔍 Market Analysis & Insights
Hands-on: This Magsafe battery has one feature I’ve been looking for [Video]
I have been on the search for a thin MagSafe battery for years. I’ve tested dozens of these battery packs, and some have been fantastic, but they all share the same compromise, which is bulk. This year’s iPhone Air made me want a thin MagSafe battery solution…
NVIDIA Stock Drops 3% Amid Geopolitical Pressures and Export Regulation Concerns
NVIDIA Corporation shares fell sharply as investors grappled with fresh reports of potential U.S. export restrictions on AI chips and broader market volatility tied to rising geopolitical tension.
Before The Matrix and The Terminator, there was ‘The Creation of the Humanoids' — how an obscure 1962 B-movie set the scene for robot takeover and introduced the concept of centralized intelligence
Before modern robots, a 1962 B-movie and 1990s MIT research reshaped machine intelligence.
College Football Jersey Patch Sponsors: Guessing power conference teams’ partnerships
Arkansas announced this week that Tyson Foods is paying to have a patch on every Razorback’s uniform, and 90 percent of the money from the deal will go to athlete NIL deals. Arkansas is the second power conference school — after LSU — to announce its jersey patch program.
Teradyne, Inc. (TER) a Moderate Buy, Say Analysts
Teradyne, Inc. (NASDAQ:TER) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026, with a stake value of over $456 million.
💰 Investment Opportunities
CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street
CRISPR Therapeutics AG (NASDAQ:CRSP) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026, with a stake value of over $551 million as of Q4.
With Trump visit coming up, China hedges its bets on helping Iran
China’s latest growth blueprint was largely written before the U.S. and Israel instigated the most far-reaching war in the Middle East in decades. Beijing now navigates support for Iran ahead of a high-profile U.S. presidential visit.
A new home for digital agriculture – University of Winnipeg News
The Manitoba Consortium for Digital Agriculture will bring together academics, farmers, government, and industry partners.
Strategic Acquisition in the Field of Uncrewed and Autonomous Systems: Rheinmetall to Gain Majority Stake in DOK-ING
The Düsseldorf-based technology group Rheinmetall is expanding its portfolio with an acquisition in the field of uncrewed systems by buying a majority stake in Croatian ground system provider DOK-ING.
OpenAI investor Vinod Khosla believes AI will be able to do 80% of all jobs by 2030. Here’s how life could be affordable after mass unemployment
The Silicon Valley billionaire laid out a vision of a deflationary economy with free healthcare and education, along with a tax overhaul to offset widespread job loss.